E
Ehsan Razeghian
Researcher at National Institute of Genetics
Publications - 11
Citations - 245
Ehsan Razeghian is an academic researcher from National Institute of Genetics. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 6 publications receiving 4 citations.
Papers
More filters
Journal ArticleDOI
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
A. Naimi,Rebar N. Mohammed,A Raji,Supat Chupradit,Alexei Valerievich Yumashev,Wanich Suksatan,Mohammed Nader Shalaby,Lakshmi Thangavelu,Siavash Kamrava,Navid Shomali,Armin D. Sohrabi,Ali Adili,Ali Noroozi-Aghideh,Ehsan Razeghian +13 more
TL;DR: A comprehensive overview of the ICI application to treat human tumors alone or in combination with other modalities to support more desired outcomes and lower toxicities in cancer patients is presented in this paper .
Journal ArticleDOI
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
A. Naimi,Rebar N. Mohammed,A Raji,Supat Chupradit,Alexei Valerievich Yumashev,Wanich Suksatan,Mohammed Nader Shalaby,Lakshmi Thangavelu,Siavash Kamrava,Navid Shomali,Armin D. Sohrabi,Ali Adili,Ali Noroozi-Aghideh,Ehsan Razeghian +13 more
TL;DR: A comprehensive overview of the ICI application to treat human tumors alone or in combination with other modalities to support more desired outcomes and lower toxicities in cancer patients is presented in this paper .
Journal ArticleDOI
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies.
Ehsan Razeghian,Mahyuddin K. M. Nasution,Heshu Sulaiman Rahman,Heshu Sulaiman Rahman,Zhanna R. Gardanova,Walid Kamal Abdelbasset,Walid Kamal Abdelbasset,Surendar Aravindhan,Dmitry Bokov,Wanich Suksatan,Pooria Nakhaei,Siavash Shariatzadeh,Faroogh Marofi,Mahboubeh Yazdanifar,Somayeh Shamlou,Roza Motavalli,Farhad Motavalli Khiavi +16 more
TL;DR: In this paper, a brief overview of the CAR-T cell application in the context of tumor immunotherapy is presented, with a special focus on CRISPR-Cas9 technology.
Journal ArticleDOI
Cloning and Embryo Splitting in Mammalians: Brief History, Methods, and Achievements
Mohaddeseh Rahbaran,Ehsan Razeghian,Marwah Suliman Maashi,Abduladheem Turki Jalil,Gunawan Widjaja,Lakshmi Thangavelu,Mariya Yurievna Kuznetsova,Pourya Nasirmoghadas,Farid Heidari,Faroogh Marofi,Mostafa Jarahian +10 more
TL;DR: Embryo splitting is one of the most widely used methods in reproductive biotechnology as discussed by the authors, and it has been extensively employed in reproductive medicine studies, such as investigating human diseases, treating sterility, embryo donation, and gene therapy.
Journal ArticleDOI
Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy.
Ehsan Razeghian,Ria Margiana,Supat Chupradit,Dmitry Bokov,Walid Kamal Abdelbasset,Faroogh Marofi,Siavash Shariatzadeh,Foad Tosan,Mostafa Jarahian +8 more
TL;DR: In this paper, mesenchymal stem/stromal cells (MSCs) have been used as a promising vehicle for cytokine delivery for human malignancies, which can lead to the more effective immune cell-induced antitumor response and provide sustained release of target cytokines.